AI Summary Radiofrequency ablation (RFA) can be curative in carefully selected patients with small, early-stage liver tumors.
Medically reviewed.
Locoregional and interventional therapies are procedures that target liver tumors directly while limiting effects on the rest of the body. Your care team may use them alone or combine them with surgery, systemic therapy, or other cancer treatments to destroy tumors, slow disease progression, preserve healthy liver tissue, and improve quality of life. This group includes histotripsy, transarterial chemoembolization (TACE), transarterial radioembolization (TARE / Y-90), radiofrequency ablation (RFA), microwave ablation (MWA), and percutaneous ethanol injection (PEI).
Providers typically choose among these options based on the size, number, and location of your liver tumors, along with your overall liver function and whether you are a candidate for surgery or transplant. This page explains how each procedure works, who may benefit, and what to expect during and after treatment. You can also connect with a liver specialist to discuss whether one of these therapies fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
LOCOREGIONAL & INTERVENTIONAL THERAPIES OVERVIEW
Locoregional and interventional therapies target liver tumors directly while limiting effects on the rest of the body. This group includes ablation methods — histotripsy, radiofrequency ablation (RFA), microwave ablation (MWA), and percutaneous ethanol injection (PEI) — and embolization-based methods — transarterial chemoembolization (TACE) and transarterial radioembolization (TARE / Y-90). These procedures may be used alone or combined with surgery, systemic therapy, or other cancer treatments to destroy tumors, slow disease progression, preserve healthy liver tissue, and improve quality of life.
Which therapy your care team recommends depends on the size, number, and location of your liver tumors, your overall liver function, and whether you can have surgery. You can explore each therapy below. Because eligibility depends on your specific diagnosis and health history, connecting with a liver specialist can help you understand which option fits your care plan.
Histotripsy is a non-invasive treatment that uses focused ultrasound energy to create microscopic bubble clouds that mechanically break down tumor cells, without incisions, needles, radiation, or heat. It may be considered for tumors not suitable for surgery or thermal ablation.
Explore this therapy:
TACE delivers chemotherapy directly into the artery feeding a liver tumor while blocking its blood supply, trapping the drug in the tumor and cutting off its oxygen and nutrients. It's often used for unresectable hepatocellular carcinoma confined mainly to the liver.
Explore this therapy:
TARE delivers radioactive Yttrium-90 microspheres — such as TheraSphere or SIR-Spheres — directly into the arteries feeding a tumor, providing localized internal radiation while sparing much of the surrounding healthy liver.
Explore this therapy:
RFA uses a needle-like probe to deliver heat that destroys small liver tumors through thermal injury. It can be curative in carefully selected patients with early-stage, accessible tumors.
Explore this therapy:
MWA uses microwave energy delivered through a probe to generate heat that destroys small to intermediate-sized tumors, often creating larger, more uniform treatment zones than some other ablation methods.
Explore this therapy:
PEI injects concentrated ethanol directly into a small tumor to cause tumor cell dehydration and death. It's generally considered when other ablation techniques aren't suitable and offers a cost-effective, repeatable option.
Explore this therapy:
Healthcare providers may recommend locoregional and interventional therapies for people with liver tumors that are unresectable, who aren't candidates for surgery or transplantation, or who need treatment to control tumor growth while awaiting transplant. The choice among options depends on tumor size, number, location, and overall liver function.
LIFESTYLE & SUPPORTIVE CARE
Locoregional and interventional therapies work best alongside supportive lifestyle habits. Care teams commonly advise a liver-friendly diet, staying well hydrated, avoiding alcohol, and easing back into light activity to support healing.
A calorie-appropriate, liver-friendly diet supports healing and helps your liver manage the workload of ongoing cancer treatment.
Staying well hydrated and avoiding alcohol supports liver recovery and is recommended after each of these procedures.
Light physical activity, as approved by your care team, supports overall recovery and helps manage fatigue between treatment sessions.
A nutrition bar designed for liver health can be a simple way to help meet daily energy and protein goals during cancer treatment.
Explore Liver Health Nutrition Bars
COMPARING LOCOREGIONAL & Interventional THERAPIES
Locoregional and interventional therapies are established options for people with liver tumors who cannot have surgery or transplantation, or who need tumor control while awaiting one. Ablation methods (histotripsy, RFA, MWA, PEI) destroy tumor tissue in place, while embolization-based methods (TACE, TARE) work through the tumor's blood supply. Providers choose among them based on tumor size, number, location, and overall liver function, and may combine or sequence therapies over the course of treatment.
These procedures are generally not as effective as surgical resection for eligible patients, but they help control disease, slow progression, and preserve quality of life for many people who are not surgical candidates. The evidence below reflects clinical and procedural outcomes reported for each therapy rather than head-to-head comparisons between them.
RFA can be curative in carefully selected patients with small, early-stage tumors, and is typically a single-session, potentially curative procedure with rapid recovery.
MWA generally creates larger, more uniform ablation zones than RFA, which can make it suitable for slightly larger or intermediate-sized tumors.
TACE and TARE are typically used for unresectable tumors confined mainly to the liver. TACE combines chemotherapy with blood-flow blockage; TARE delivers targeted internal radiation via Yttrium-90 microspheres while sparing more healthy liver tissue.
Histotripsy is a newer, non-invasive option that uses focused ultrasound rather than heat, radiation, or incisions, and may be considered when a patient isn't a candidate for thermal ablation.
TREATMENT MONITORING
Regular monitoring helps your care team see how your liver is responding to treatment and catch complications early. Your team will ask about procedure-related side effects, which can include post-embolization syndrome after TACE or TARE, abdominal discomfort, mild pain near the treatment site, and temporary elevation of liver enzymes after ablation procedures.
Liver function tests track enzymes and other markers that show how your liver is responding after a procedure and help flag any changes early.
Follow-up imaging (ultrasound, CT, or MRI) confirms whether the treated tumor was successfully destroyed or controlled and screens for recurrence.
Your oncology and liver care teams coordinate follow-up visits to decide whether repeat treatment, a different locoregional option, or another therapy is needed.
Only a qualified healthcare provider can adjust your treatment plan based on your test results and health history.
COMMON QUESTIONS
Locoregional and interventional therapies are procedures that target liver tumors directly, including histotripsy, transarterial chemoembolization (TACE), transarterial radioembolization (TARE / Y-90), radiofrequency ablation (RFA), microwave ablation (MWA), and percutaneous ethanol injection (PEI). They may be used alone or with surgery or systemic therapy to destroy tumors, slow progression, and preserve healthy liver tissue. Talk with your liver specialist about whether one fits your treatment plan.
Ablation methods like RFA, MWA, PEI, and histotripsy destroy tumor tissue directly using heat, ethanol, or focused ultrasound energy. Embolization-based methods like TACE and TARE work through the tumor's blood supply — TACE combines chemotherapy with blocking blood flow, while TARE delivers radioactive Yttrium-90 microspheres. Your care team chooses an approach based on your tumor's size, number, and location, and your liver function.
Healthcare providers may recommend these therapies for people with liver tumors that are unresectable, who aren't candidates for surgery or transplantation, or who need tumor control while awaiting transplant. RFA is often considered for small, early-stage tumors, while TACE and TARE are more often used for larger or unresectable disease. Eligibility depends on your specific diagnosis and health history.
RFA can be potentially curative for small, early-stage tumors in carefully selected patients. Other therapies, including TACE, TARE, MWA, PEI, and histotripsy, are generally used for tumor control and disease-progression management rather than cure, and are often repeated over time based on tumor response. These procedures are generally not as effective as surgical resection for patients eligible for surgery. Discuss your specific expectations and monitoring plan with your healthcare provider.
Common side effects vary by procedure but often include abdominal discomfort, fatigue, mild pain or fever near the treatment area, and temporary liver enzyme elevation. TACE and TARE can cause post-embolization syndrome (pain, fever, nausea, fatigue). Serious complications, such as bleeding or infection, are uncommon but possible. Your care team will monitor you and can help manage any side effects.
Most of these procedures are minimally invasive or non-invasive, performed under imaging guidance, and many allow same-day or overnight recovery. Histotripsy is fully non-invasive, using focused ultrasound with no incisions or needles. Ablation procedures (RFA, MWA, PEI) use a thin probe or needle inserted through the skin. TACE and TARE use a catheter inserted through an artery, typically in the groin or wrist. Recovery time depends on the specific procedure and your overall health.
After treatment, your care team will schedule follow-up imaging to check whether the tumor was destroyed or controlled and to watch for recurrence. You'll also have periodic blood tests to monitor liver function. Maintaining a liver-friendly diet, staying hydrated, and avoiding alcohol support recovery between and after procedures. Your oncology and liver specialists coordinate this follow-up together.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
